// App-Quantinova.ai

: Fondaparinux in Patients with Heparin‐induced Thrombocytopenia and Dialysis; A Case Report, and Systematic Review of Available Literature

Researchers

Presenter

  • M. Wanat

Principal Investigators

  • M. Gillette

  • E. Sulaica

  • A. Denktas

Medical Centers

  • University of Houston College of Pharmacy, Department of Pharmacy Practice and Translational Research, Houston, United States

  • Michael E. DeBakey VA Medical Center, Department of Pharmacy, Houston, United States

  • Baylor College of Medicine and the Michael E. DeBakey VA Medical Center, Division of Cardiology, Houston, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Thrombocytopenia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Fondaparinux sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved